Elizabeth Bullock
Papers
1
Total Citations
21
H-Index
1
About
Elizabeth Bullock is a leading clinical researcher in radiation oncology, with a focused expertise in advanced treatment techniques for prostate cancer. Her work centers on optimizing therapeutic ratios by integrating intensity-modulated radiation therapy (IMRT) with stereotactic body radiation therapy (SBRT) boosts, offering a less invasive alternative to traditional brachytherapy. Her most cited study, a 2017 report on 3-year toxicity outcomes for unfavorable prostate cancer patients, demonstrated that combining IMRT with an SBRT boost yields favorable safety profiles while maintaining oncologic efficacy. This work, cited 21 times, has helped establish SBRT as a viable, non-invasive boost strategy, reducing procedural morbidity without compromising disease control. Bullock’s contributions are pivotal in shaping modern prostate cancer management, bridging the gap between conventional fractionation and hypofractionated approaches. Her research continues to influence clinical guidelines and patient counseling, underscoring her role as a key figure in the evolution of precision radiotherapy. For students and clinicians, her work exemplifies how rigorous toxicity analysis can drive innovation in treatment delivery.
Research Focus
Key Achievements
Top Papers
- 1